Cargando…
Association of carbamylated high-density lipoprotein with coronary artery disease in type 2 diabetes mellitus: carbamylated high-density lipoprotein of patients promotes monocyte adhesion
BACKGROUND: Increasing evidence showed that carbamylated lipoprotein accelerated atherosclerosis. However, whether such modification of high-density lipoprotein (HDL) particles alters in type 2 diabetes mellitus (T2DM) patients and facilitates vascular complications remains unclear. We aimed to inve...
Autores principales: | Chen, Zhongli, Ding, Song, Wang, Yan Ping, Chen, Liang, Mao, Jing Yan, Yang, Ying, Sun, Jia Teng, Yang, Ke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7713164/ https://www.ncbi.nlm.nih.gov/pubmed/33272295 http://dx.doi.org/10.1186/s12967-020-02623-2 |
Ejemplares similares
-
The effect of carbamylation on the functionality of high-density lipoprotein
por: Holzer, Michael, et al.
Publicado: (2009) -
Carbamylated lipoproteins in diabetes
por: Denimal, Damien
Publicado: (2023) -
Evalution of In Vitro Effect of Flavonoids on Human Low-Density Lipoprotein Carbamylation
por: Ghaffari, Mohammad Ali, et al.
Publicado: (2010) -
Carbamylated Low-Density Lipoprotein (cLDL)-Mediated Induction of Autophagy and Its Role in Endothelial Cell Injury
por: Bose, Chhanda, et al.
Publicado: (2016) -
Serum Levels of Carbamylated LDL and Soluble Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 Are Associated with Coronary Artery Disease in Patients with Metabolic Syndrome
por: Stankova, Teodora, et al.
Publicado: (2019)